Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

PHASE4CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

March 8, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Tick Borne EncephalitisVirus Diseases
Interventions
OTHER

Blood draw

Annual blood draw at years 6 (Visit 18), 7 (Visit 19), 8 (Visit 20), 9 (Visit 21) and 10 (Visit 22)

Trial Locations (1)

50002

GSK Investigational Site, Hradec Králové

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY